Action mechanism of tachyplesin I and effects of PEGylation

被引:156
作者
Imura, Yuichi
Nishida, Minoru
Ogawa, Yoshiyuki
Takakura, Yoshinobu
Matsuzaki, Katsumi [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2007年 / 1768卷 / 05期
关键词
antimicrobial peptide; tachyplesin I; PEGylation; lipid flip-flop; peptide-lipid interaction; membrane permeabilization;
D O I
10.1016/j.bbamem.2007.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PEGylation of protein and peptide drugs is frequently used to improve in vivo efficacy. We investigated the action mechanism of tachyplesin 1, a membrane-acting cyclic antimicrobial peptide from Tachypleus tridentatus and the effects of PEGylation on the mechanism. The PEGylated peptide induced the leakage of calcein from egg yolk L-alpha-phosphatidylglycerol/egg yolk L-alpha-phosphatidylcholine large unilamellar vesicles similarly to the parent peptide. Both peptides induced lipid flip-flop coupled to leakage and was translocated into the inner leaflet of the bilayer, indicating that tachyplesin I forms a toroidal pore and that PEGylation did not alter the basic mechanism of membrane permeabilization of the parent peptide. Despite their similar activities against model membranes, the peptides showed very different biological activities. The cytotoxicity of tachyplesin I was greatly reduced by PEGylation, although the antimicrobial activity was significantly weakened. We investigated the enhancement of the permeability of inner membranes induced by the peptides. Our results suggested that outer membranes and peptidoglycan layers play an inhibitory role in the permeation of the PEG moiety. Furthermore, a reduction in DNA binding by PEGylation may also contribute to the weak activity of the PEGylated peptide. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1160 / 1169
页数:10
相关论文
共 56 条
[1]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[2]   LIPOSOMAL ENTRAPMENT OF THE NEUTROPHIL-DERIVED PEPTIDE INDOLICIDIN ENDOWS IT WITH IN-VIVO ANTIFUNGAL ACTIVITY [J].
AHMAD, I ;
PERKINS, WR ;
LUPAN, DM ;
SELSTED, ME ;
JANOFF, AS .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :109-114
[3]  
AKAJI K, 1989, CHEM PHARM BULL, V37, P2661
[4]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[5]   PRODUCTION AND ULTRASTRUCTURE OF LYSOZYME AND ETHYLENEDIAMINETETRAACETATE-LYSOZYME SPHEROPLASTS OF ESCHERICHIA COLI [J].
BIRDSELL, DC ;
COTAROBL.EH .
JOURNAL OF BACTERIOLOGY, 1967, 93 (01) :427-+
[6]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[7]   Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates [J].
Caliceti, P ;
Veronese, FM .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (10) :1261-1277
[8]   BETA-LACTAM ANTIBIOTICS POTENTIATE MAGAININ-2 ANTIMICROBIAL ACTIVITY INVITRO AND INVIVO [J].
DARVEAU, RP ;
CUNNINGHAM, MD ;
SEACHORD, CL ;
CASSIANOCLOUGH, L ;
COSAND, WL ;
BLAKE, J ;
WATKINS, CS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1153-1159
[9]   Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-α2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2 [J].
Dhalluin, C ;
Ross, A ;
Huber, W ;
Gerber, P ;
Brugger, D ;
Gsell, B ;
Senn, H .
BIOCONJUGATE CHEMISTRY, 2005, 16 (03) :518-527
[10]   Peptide-lipid interactions of the β-hairpin antimicrobial peptide tachyplesin and its linear derivatives from solid-state NMR [J].
Doherty, Timothy ;
Waring, Alan J. ;
Hong, Mei .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09) :1285-1291